Particle.news
Download on the App Store
3 ARTICLES
·
last wk.

Indian Markets Brace for Q4 Earnings Divergence and Regulatory Developments

Investors focus on profit growth at Divi’s and Zen, Vodafone Idea’s AGR plea, and major order wins by BEL and KEC as markets prepare for Monday’s open.

Top stocks to watch: Dr Reddy's, BEL, Divis Labs, Bajaj Auto, Sun Pharma, JSW Steel & Premier Energies
Image

Overview

  • Divi’s Laboratories reported a 25.6% year-on-year profit jump to Rs 667 crore, with revenue rising 12.26% to Rs 2,536 crore, and announced a Rs 30 per share dividend.
  • Zen Technologies posted a 189% surge in net profit to Rs 101.04 crore, driven by a 130% increase in revenue to Rs 324.97 crore for Q4FY25.
  • Vodafone Idea approached the Supreme Court seeking a waiver of Rs 45,457 crore in adjusted gross revenue dues, highlighting ongoing financial strain in the telecom sector.
  • Bharat Electronics secured Rs 572 crore in new defence contracts, while KEC International announced Rs 1,133 crore in transmission and distribution project orders.
  • Dr Reddy’s Laboratories received two USFDA observations following a GMP inspection at its API facility in Middleburgh, New York, conducted from May 12 to May 16.